The information line is fully staffed by librarians, according to the announcement. City officials say it handles an average ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with little-known U.S. artificial intelligence research biotech Earendil Labs in a ...

Third along the course is Framingham, Massachusetts' newest city. It transitioned from being a town to a mayor-and-council government in 2018. Athletes pass through the city on Route 135 ...

Sanofi’s blockbuster ambitions for amlitelimab hit a bump in the road this morning with the news that the highest dose of the anti-OX40-ligand monoclonal antibody missed the main goal of a phase ...

Sanofi plans a phase 3 amlitelimab trial; safety remained consistent over 60 weeks of treatment. China’s new tariffs just reignited the same market patterns that led to triple- and quadruple ...

Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...

But the up-front costs are large, so pilot projects like one in Framingham, Massachusetts, are using the deep pockets of gas utilities to build geothermal networks that collect affordable payments ...

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma. Amlitelimab: ...

At least seven human remains found across Connecticut, Rhode Island and Massachusetts between March and April warrant "review and investigation," according to Pennsylvania-based criminal defense ...